Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL

Eventide Asset Management, LLC reported a 6.28% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Eventide Asset Management, LLC reported a 6.28% stake in Zentalis Pharmaceuticals, Inc., 4,475,054 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
6.28%
Shares
4,475,054
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Eventide Asset Management, LLC6.28%4,475,054
Finny Kuruvilla, M.D., Ph. D.6.28%4,475,054
Robin C. John6.28%4,475,054

Source

View original at SEC

Related